{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:13:14Z","timestamp":1792249994044,"version":"4.4.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.bbr.2013.08.049","type":"journal-article","created":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T12:47:03Z","timestamp":1378385223000},"page":"545-553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Reappraisal of spontaneous stereotypy in the deer mouse as an animal model of obsessive-compulsive disorder (OCD): Response to escitalopram treatment and basal serotonin transporter (SERT) density"],"prefix":"10.1016","volume":"256","author":[{"given":"De Wet","family":"Wolmarans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan J.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian H.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2013.08.049_bib0005","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.physbeh.2011.03.008","article-title":"Cortico-striatal oxidative status, dopamine turnover and relation with stereotypy in the deer mouse","volume":"103","author":"G\u00fcldenpfennig","year":"2011","journal-title":"Physiol Behav"},{"key":"10.1016\/j.bbr.2013.08.049_bib0010","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.pnpbp.2007.08.032","article-title":"Stereotypic behaviour in the deer mouse: pharmacological validation and relevance for obsessive compulsive disorder","volume":"32","author":"Korff","year":"2008","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bbr.2013.08.049_bib0015","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.pbb.2009.01.025","article-title":"Cortico-striatal cyclic AMP-phosphodiesterase-4 signalling and stereotypy in the deer mouse: attenuation after chronic fluoxetine treatment","volume":"92","author":"Korff","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2013.08.049_bib0020","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.bbr.2013.08.049_bib0025","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.brat.2008.05.006","article-title":"The status of hoarding as a symptom of obsessive-compulsive disorder","volume":"46","author":"Abramowitz","year":"2008","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.bbr.2013.08.049_bib0030","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.pnpbp.2005.11.003","article-title":"Is obsessive-compulsive disorder an anxiety disorder?","volume":"30","author":"Bartz","year":"2006","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bbr.2013.08.049_bib0035","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.mppsy.2007.04.001","article-title":"Pharmacological treatment for obsessive-compulsive disorder","volume":"6","author":"Fineberg","year":"2007","journal-title":"Psychiatry"},{"key":"10.1016\/j.bbr.2013.08.049_bib0040","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.pnpbp.2005.11.005","article-title":"Mechanisms of action of current and potential pharmacotherapies of obsessive-compulsive disorder","volume":"30","author":"El Mansari","year":"2006","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bbr.2013.08.049_bib0045","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1017\/S0033291701003579","article-title":"The relationship between obsessive-compulsive disorder and anxiety and affective disorders: results from the Johns Hopkins OCD family study","volume":"31","author":"Nestadt","year":"2001","journal-title":"Psychol Med"},{"key":"10.1016\/j.bbr.2013.08.049_bib0050","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/00004850-200008002-00003","article-title":"Pharmacotherapy of obsessive-compulsive disorder: experience with the selective serotonin reuptake inhibitors","volume":"15","author":"Vythilingum","year":"2000","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.bbr.2013.08.049_bib0055","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cpr.2009.09.005","article-title":"Multiple pathways to functional impairment in obsessive-compulsive disorder","volume":"30","author":"Markarian","year":"2010","journal-title":"Clin Psychol Rev"},{"key":"10.1016\/j.bbr.2013.08.049_bib0060","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1017\/S0954579408000606","article-title":"The neural bases of obsessive \u2013 compulsive disorder in children and adults","volume":"20","author":"Maia","year":"2008","journal-title":"Dev Psychopathol"},{"key":"10.1016\/j.bbr.2013.08.049_bib0065","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.janxdis.2011.03.002","article-title":"Serotonin transporter gene polymorphism implicates reduced orbito-frontal cortex in obsessive-compulsive disorder","volume":"25","author":"Atmaca","year":"2011","journal-title":"J Anxiety Disord"},{"key":"10.1016\/j.bbr.2013.08.049_bib0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuroimage.2009.07.069","article-title":"Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study","volume":"49","author":"Matsumoto","year":"2010","journal-title":"Neuroimage"},{"key":"10.1016\/j.bbr.2013.08.049_bib0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pscychresns.2005.07.002","article-title":"Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder","volume":"140","author":"Hesse","year":"2005","journal-title":"Psychiatry Res \u2013 Neuroimaging"},{"key":"10.1016\/j.bbr.2013.08.049_bib0080","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s00702-007-0785-6","article-title":"Reduced availability of serotonin transporters in obsessive-compulsive disorder correlates with symptom severity \u2013 A [11C]DASB PET study","volume":"114","author":"Reimold","year":"2007","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bbr.2013.08.049_bib0085","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1038\/npp.2008.35","article-title":"Changes in thalamus-hypothalamus serotonin transporter availability during clomipramine administration in patients with obsessive-compulsive disorder","volume":"33","author":"Zitterl","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2013.08.049_bib0090","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.neubiorev.2010.02.004","article-title":"The neurobiology of repetitive behavior: of mice\u2026","volume":"35","author":"Langen","year":"2011","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.bbr.2013.08.049_bib0095","first-page":"5","article-title":"The epidemiology and differential diagnosis of obsessive compulsive disorder","volume":"55","author":"Rasmussen","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.bbr.2013.08.049_bib0100","series-title":"Animal models of psychiatric disorders psychopharmacology fourth generation of progress","author":"Geyer","year":"2000"},{"key":"10.1016\/j.bbr.2013.08.049_bib0105","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.pnpbp.2005.11.006","article-title":"Current animal models of obsessive compulsive disorder: a critical review","volume":"30","author":"Joel","year":"2006","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bbr.2013.08.049_bib0110","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.psc.2006.02.007","article-title":"Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology","volume":"29","author":"Korff","year":"2006","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.bbr.2013.08.049_bib0115","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0278-5846(00)00104-4","article-title":"Natural animal models of human psychiatric conditions: assessment of mechanism and validity","volume":"24","author":"Overall","year":"2000","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bbr.2013.08.049_bib0120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbr.2011.02.010","article-title":"Predictive validity of a non-induced mouse model of compulsive-like behavior","volume":"221","author":"Greene-Schloesser","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2013.08.049_bib0125","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/FBP.0b013e32832a80ad","article-title":"Assessing the validity of current mouse genetic models of obsessive-compulsive disorder","volume":"20","author":"Wang","year":"2009","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.bbr.2013.08.049_bib0130","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/npp.2009.185","article-title":"Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review","volume":"35","author":"Fineberg","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2013.08.049_bib0135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neuroscience.2011.08.070","article-title":"Current animal models of obsessive compulsive disorder: an update","volume":"211","author":"Albelda","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2013.08.049_bib0140","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.applanim.2005.08.006","article-title":"Spontaneous stereotypy and environmental enrichment in deer mice (Peromyscus maniculatus): reversibility of experience","volume":"97","author":"Hadley","year":"2006","journal-title":"Appl Anim Behav Sci"},{"key":"10.1016\/j.bbr.2013.08.049_bib0145","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0006-3223(98)00154-1","article-title":"Effect of long-term administration of antidepressant treatments on serotonin release in brain regions involved in obsessive-compulsive disorder","volume":"45","author":"Bergqvist","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2013.08.049_bib0150","series-title":"Animal and translational models for CNS drug discovery","first-page":"133","article-title":"Animal models of obsessive-compulsive disorder: from bench to bedside via endophenotypes and biomarkers","author":"Joel","year":"2008"},{"key":"10.1016\/j.bbr.2013.08.049_bib0155","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jocrd.2012.08.001","article-title":"Assessing obsessive-compulsive disorder (OCD): a review of self-report measures","volume":"1","author":"Overduin","year":"2012","journal-title":"J Obsessive-Compulsive Relat Disord"},{"key":"10.1016\/j.bbr.2013.08.049_bib0160","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/archpsyc.1989.01810110054008","article-title":"The Yale-brown obsessive compulsive scale. II. Validity","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bbr.2013.08.049_bib0165","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/jclp.20382","article-title":"Florida obsessive-compulsive inventory: development, reliability, and validity","volume":"63","author":"Storch","year":"2007","journal-title":"J Clin Psychol"},{"key":"10.1016\/j.bbr.2013.08.049_bib0170","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1037\/a0018260","article-title":"Assessment of obsessive-compulsive symptom dimensions: development and evaluation of the dimensional obsessive-compulsive scale","volume":"22","author":"Abramowitz","year":"2010","journal-title":"Psychol Assess"},{"key":"10.1016\/j.bbr.2013.08.049_bib0175","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1037\/1040-3590.17.2.132","article-title":"Screening for obsessive and compulsive symptoms: validation of the Clark-Beck obsessive-compulsive inventory","volume":"17","author":"Clark","year":"2005","journal-title":"Psychol Assess"},{"key":"10.1016\/j.bbr.2013.08.049_bib0180","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0031-9384(98)00303-5","article-title":"A rodent model of spontaneous stereotypy: initial characterization of developmental, environmental, and neurobiological factors","volume":"66","author":"Powell","year":"1999","journal-title":"Physiol Behav"},{"key":"10.1016\/j.bbr.2013.08.049_bib0185","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0006-3223(01)01145-3","article-title":"Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine","volume":"50","author":"Owens","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2013.08.049_bib0190","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0939-8600(00)80009-7","article-title":"Nicotine consumption of several mouse strains using a two bottle choice paradigm","volume":"40","author":"Aschhoff","year":"2000","journal-title":"J Exp Anim Sci"},{"key":"10.1016\/j.bbr.2013.08.049_bib0195","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.bbr.2004.08.003","article-title":"Striatal opioid peptide content in an animal model of spontaneous stereotypic behavior","volume":"157","author":"Presti","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2013.08.049_bib0200","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.pbb.2003.12.004","article-title":"Behavior-related alterations of striatal neurochemistry in a mouse model of stereotyped movement disorder","volume":"77","author":"Presti","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2013.08.049_bib0205","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.brainres.2010.05.054","article-title":"Chronic buspirone treatment decreases 5-HT1B receptor densities and the serotonin transporter but increases the density of 5-HT2A receptors in the bulbectomized rat model of depression: an autoradiographic study","volume":"1345","author":"Sato","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2013.08.049_bib0210","first-page":"487","article-title":"Obsessive-compulsive disorder: efficacy of specific treatments as assessed by controlled trials","volume":"29","author":"Jenike","year":"1993","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.bbr.2013.08.049_bib0215","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3928\/00485713-20060701-07","article-title":"Pharmacologic strategies for treatment-resistant OCD: a review of the evidence","volume":"36","author":"Fineberg","year":"2006","journal-title":"Psychiatric Ann"},{"key":"10.1016\/j.bbr.2013.08.049_bib0220","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.pnpbp.2009.12.001","article-title":"Accelerating response to antidepressant treatment in depression: a review and clinical suggestions","volume":"34","author":"Nakajima","year":"2010","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bbr.2013.08.049_bib0225","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0193-953X(05)70181-7","article-title":"Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder","volume":"23","author":"Saxena","year":"2000","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.bbr.2013.08.049_bib0230","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0893-6080(02)00052-7","article-title":"Opponent interactions between serotonin and dopamine","volume":"15","author":"Daw","year":"2002","journal-title":"Neural Netw"},{"key":"10.1016\/j.bbr.2013.08.049_bib0235","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s002130051170","article-title":"Selective destruction of brain serotonin neurons by 5,7-dihydroxytryptamine increases responding for a conditioned reward","volume":"147","author":"Fletcher","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2013.08.049_bib0240","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tics.2007.10.011","article-title":"Serotoninergic regulation of emotional and behavioural control processes","volume":"12","author":"Cools","year":"2008","journal-title":"Trends Cogn Sci (Regul Ed)"},{"key":"10.1016\/j.bbr.2013.08.049_bib0245","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pscychresns.2011.06.006","article-title":"Serotonin 2A receptor, serotonin transporter and dopamine transporter alterations in dogs with compulsive behaviour as a promising model for human obsessive-compulsive disorder","volume":"201","author":"Vermeire","year":"2012","journal-title":"Psychiatry Res: Neuroimaging"},{"key":"10.1016\/j.bbr.2013.08.049_bib0250","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.biopsych.2011.07.032","article-title":"Essential role for orbitofrontal serotonin 1B receptors in obsessive-compulsive disorder-like behavior and serotonin reuptake inhibitor response in mice","volume":"70","author":"Shanahan","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2013.08.049_bib0255","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00213-013-2976-1","article-title":"Effects of the serotonergic agonist mCPP on male rats in the quinpirole sensitization model of obsessive-compulsive disorder (OCD)","volume":"227","author":"Tucci","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2013.08.049_bib0260","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.biopsych.2005.02.020","article-title":"Reinforced spatial alternation as an animal model of obsessive-compulsive disorder (OCD): investigation of 5-HT2C and 5-HT1D receptor involvement in OCD pathophysiology","volume":"57","author":"Tsaltas","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2013.08.049_bib0265","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00213-008-1241-5","article-title":"Dopaminergic and serotonergic modulation of persistent behaviour in the reinforced spatial alternation model of obsessive-compulsive disorder","volume":"200","author":"Kontis","year":"2008","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432813005469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432813005469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T03:33:59Z","timestamp":1596425639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432813005469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":53,"alternative-id":["S0166432813005469"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2013.08.049","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reappraisal of spontaneous stereotypy in the deer mouse as an animal model of obsessive-compulsive disorder (OCD): Response to escitalopram treatment and basal serotonin transporter (SERT) density","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2013.08.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}